Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
MICT +140% after hours MICT and Brookfield Interactive (Hong Kong) Ltd sign a definitive acquisition agreement with ParagonEx
$MGON
$HEMP Hemp, Inc. Featured in Caribbean Business as Puerto Rico Rolls Out Industrial Hemp Program https://www.marketwatch.com/press-release/hemp-inc-featured-in-caribbean-business-as-puerto-rico-rolls-out-industrial-hemp-program-2018-12-06
Anyone know anything about NSPX?
Insys Therapeutics $INSY Before Medical Marijuana Reaches A Tipping Point https://www.forbes.com/sites/kenkam/2016/06/21/buy-insys-therapeutics-before-medical-marijuana-reaches-a-tipping-point/#136b5a0d5d30
$INSY NO BRAINER!
News!!! $INSY INSYS Therapeutics Provides Update on Strategic Alterative Review Process and Product Pipeline Spanning Pharmaceutical Cannabinoids and Spray Technology https://www.einnews.com/pr_news/471329870/insys-therapeutics-provides-update-on-strategic-alterative-review-process-and-product-pipeline-spanning-pharmaceutical-cannabinoids-and-spray
$CIIX not only was CBD their $CIIX CBD wasn't their only revenue leader. Their #cryptocurrency lines generated a 1,062% increase up $206,648 for the fiscal year ended May 31, 2018, compared to $19,453 for the fiscal year ended May 31, 2017.
Top 4 Beverage Companies stocks on Wall Street Entering cannabis CBD infused drinks 1. $NBEV 2. $CIIX 3. $GWPH 4. $ACB
https://www.marketwatch.com/press-release/top-beverage-companies-entering-cbd-2018-10-10 …
NDRA Pr just out. Still stick to previous commercialization date of its TAEUS liver device "expected in Europe in mid-2019"
Are you still in NDRA?
$CIIX Usages and benefits of CBD
According to a series of documentary reports, CBD has shown to be effective in treating epilepsy, Alzheimer?s disease, cirrhosis of the liver and to provide relief from hangover, anxiety and stress.
http://chineseinvestors.com/opportunities-in-cbd/
$HEMP Hemp, Inc. has created strategic partnerships with farmers across the U.S. in states including North Carolina and Oregon to provide them with services including drying, curing and storing of industrial hemp. In addition, Hemp, Inc. is also ramping up development of a Veteran Village Kins Community in Arizona that will support hemp growing and manufacturing as well as provide additional wellness supports to the local community. As Perlowin recently told Southern Oregon's local National Public Radio station, Jefferson Public Radio, the company is rapidly expanding its footprint with the development of Local Processing Centers to support family farms across America.
AVGR- low float, just closed offering and pending FDA approval soon. Catalyst play. Trading around .35
Pain Therapeutics Announces Initiation of a Phase II Study in Alzheimer’s Disease.
https://globenewswire.com/news-release/2018/12/06/1662961/0/en/Pain-Therapeutics-Announces-Initiation-of-a-Phase-II-Study-in-Alzheimer-s-Disease.html
Aytu BioScience Announces Closing of $5M Investment from Armistice Capital
Strategic Investment Positions Company with Approximately $19M in Cash VS $8.8M Market cap!!!
https://www.accesswire.com/viewarticle.aspx?id=529423
CBD Company Announces Amazing Results, one of our favorite CBD companies released some fantastic news. https://finance.yahoo.com/news/cbd-company-announces-amazing-results-165000329.html
BOSC when you do DD you know what you own for the long term
B.O.S. Reports Third Quarter Revenue Growth of 6.7%; Net Income Increases by 63.6%
Personally I want a cash deal and then I won’t care about the listing at all.
Hi Ash I saw this today on BNN ADVFN England board about reverse mergers and listing on NASDAQ and I am wondering if these rule would apply to MICT if this reverse merger goes through in regards to this new company being listed on the NASDAQ at this link.
https://www.sec.gov/rules/sro/nasdaq/2017/34-80888.pdf
At link I posted above one scenario requires a $4 NASDAQ listing price minimum and another alternative price minimum of at least $2 or $3 on NASDAQ
Member mars00 posted this link above today on the BNN ADVFN Board in England and I posted direct link to that board if you want to read this for yourself. I am thinking if an eventual listing on the NASDAQ would occur for this new future company if this reverse merger goes through between MICT BNN and a third party at the very minimum $2 this would be a huge increase from share price today and even a 67% gain for me with my average of $1.20 a share for MICT. Would these be the correct SEC laws that would apply if this reverse merger goes through.
https://uk.advfn.com/stock-market/london/bnn-technology-BNN/share-chat?
MICT will have C.C next week, I guess they will refer it. stock is up 85% now
Do you think the BNN merger will go through for MICT?
ER was good, but People have lost confidence, it seems due to concern about the merger with BNN.
MICT... Thoughts on this, ash?
MICT... yes, it does. I wonder when this BNN buyout will happen?
thanks tom, makes sense, though the degree of the drop seems a bit much
MICT... check out the MICT forum, msg# 348
MICT - i don't follow the story very closely. what happened today? worth a buy down here?
$TREP Fib retracement complete@ this should bounce!
Thanks for your comments Ash. I am continuing to hold my shares in hopes that a merger with MICT BNN and a 3rd party will be finalized sometime in December.
MTH4, you have described it well. Not sure if I have something else to add. During Bear Market, it hards to predict which way the stock moves. Even solid Companies could tank, but if you are doing good DD, you can usually predict well, for the mid-long term.
EYEG- 40% insider owned, 2 x positive data from 2 studies - low float
Ash do not know if you are still holding your MICT shares but there is a lot going on from postings I have been reading at this BNN board link below with 150 messages posted from November 11 to November 13 so far today. Sentiment there seems a deal will be done sometime in December and the new company from this merger will be uplisted to the NASDAQ on January1 2019. Let us know here what your opinion is about these new developments going on with MICT when you get a chance to reasearch further.
https://uk.advfn.com/stock-market/london/bnn-technology-BNN/share-chat?nomobile
Check out MICT today at 77 cents. MICT is in a merger process with BNN and a third party that could be finalized in the near future. Much discussion at board below that deal will be done in December sometime and the new company will be uplisted to the NASDAQ January 1 2019. 150 messages have been posted on BNN board in England at link below between November 11 and so far today November 13.
There has been a lot of discussions going at this BNN board in England concerning the merger of MICT with BNN and a third party and you can read all about it at the link below for your information. You can also get a free membership with them to post new messages and respond back to messages.
https://uk.advfn.com/stock-market/london/bnn-technology-BNN/share-chat?nomobile
$CIIX CBD Medical Marijuana Alert $CIIX Next month Infused Drinks should be announcing based on previous report
$SBOT $AYTU trading a half Cash on hand. Catalysts. $PTIE had solid news today. trading under Equity. These low float companies are very cheap. low burn ( aytu burn dropped by 40%). They will pop when you least expect it
$S
PTIE Pain Therapeutics Appeals FDA Decision on REMOXY http://www.globenewswire.com/news-release/2018/11/12/1649568/0/en/Pain-Therapeutics-Appeals-FDA-Decision-on-REMOXY.html
DTEA - not long or short or even sitting with lower bids. Just watching for now.... You had posted so much about it here that i thought i'd try to see what longtime shareholders and/or shorts were saying about it over at S.Alpha.
Btw. most authors are mostly wrong most of the time. That's why you should never buy/sell based on these opinions especially when you can not verify if they are in long or short position. Always do your own DD too
Maybe that's the reason DTEA refused to talk about it that day, but with/without CBD, it worth not less than $640m, based on purchase prices Unilever paid past year for 2 Tea Makers Companies which had worse balance sheet.they paid 4 times revenues per estimations, $160m for Pukka which did only $40m, DTEA doing X4, and has no competition in Canada. Company doing X10 revenues than TLRY, Net Assets X3, Cash on Hand X2. Every economist will confirm based on current Net Assets that share price is higly undervalued.
just hired 2 people who work and are directors of Cannabis Company, and CEO commented past earnings a month ago:
Herschel Segal: "we have made adjustments at head office to change our operations and our culture. We are building a strong team and we have put more senior leaders in buying, marketing and product development. We are also paying more attention to our costs. As well, we are ready to find a CEO who will enthusiastically adapt to the DAVIDsTEA environment, lead with a realistic optimism and bring vision that will be refined and further developed with the senior executive team and the company's board".
Owner avg. purchase price is $21.4 and still holding all. There is a solid reason why. he is waiting the bid deal. Im holding for $20-$25/sh the long term. Days will tell.
Btw, you own shares, long/short or just hoping to get some on better price?
DTEA - Ash, the biggest problem with this co. is the quality of the management team, judging from shareholder comments going back a few years over at S.Alpha articles.
Young founder David Segal left in 2016 and his cousin Herschel (a big loser on his publicly-traded Canadian garment biz) has done nothing but run the DTEA stockprice into the ground the past two years.
Big investor money has fled, especially in the past 6 weeks with TDM, then EdgePoint, then finally Highland all selling out (well, TDM still has a measly 10% of their shares). Those were DTEA's three biggest institutional investors. Doesn't inspire much confidence....
There are big doubts about whether DTEA could sell any CBD products at its provincial stores because of NOT HAVING A LICENSE.
They've brought on a board member with experience in the CBD biz but has DTEA even begun filing for a license to sell CBD products at any of its stores? Apparently not, according to this S.Alpha author Cornerstone from Oct. 3, 2018:
https://seekingalpha.com/article/4209712-davids-tea-latest-victim-current-cannabis-frenzy
[...] any form of participation between DAVIDs TEA and cannabis firms would be subject to the rules and regulations regarding the sale and distribution of cannabis. Shoppers Drug Mart (OTCPK:LBLCF) was awarded its license and it plans to start selling cannabis through its pharmacies once legalization begins on October 17th. However, DAVIDs TEA has not applied for any cannabis license as far as we know and its business plan does not involve cannabis retailing at this point, which means that potential partners would not be able to sell cannabis through DAVIDs TEA because the latter does not have a license. Getting a license could take months to a year and there is no guarantee that DAVIDs TEA would be successful in obtaining one. Thus, we think the path to a partnership is still nothing but uncertain.
Final Words
DAVIDs TEA has a core business in selling tea that has been struggling for years. When you add cannabis into the mix, investors start to fancy all sorts of possibilities and before you know share price is up 63% in one day. However, this is a company that has failed to turn around its core operations since its IPO and its same-store traffic continues to decline at an alarming rate. If you are investing in DAVIDs TEA with the hope that its fate could be transformed by the cannabis sector, you need to recognize that the underlying stock is not worth nearly where it closed on Tuesday. The stock has been a disappointment after losing 87% of its value since IPO just three years ago. Will cannabis save DAVIDs TEA? We don't think so, and certainly, you should not bet your hard-earned money on this stock.
O.k found it. Wow.
Scarborough Eddie, is so right. I basically came to same conclusion, read my previous post. Is he commented to this article? I can't see his comments.do you have a link?
Thanks for sharing.Fits my DD about DTEA: I also mentioned that Unilever acquired Pukka for about $160m(est. 4 times sales as mentioned in your article).Pukka was doing $39m, DTEA doing X4. thats should be $640m. Co. has $90m Net Assets, $40M Cash. Immediate valuation per this alone is about $3.6/sh ($90m/25m O/S).
If Put CBD in their Tea, theoretically should be trading $100B, doing X10 Rev than $TLRY, net assets X3 either. Cash X2, MC only $55m.
they are already well settled and no marketing issue, 240 corp stores 450 Loblaws.
New CEO will be announced any time soon. CEO commented (Q2 Transcript a month ago) :
"we have made adjustments at head office to change our operations and our culture". "we are ready to find a CEO...just hired 2 ppl who work and are directors of Cannabis Co. One is Anne Darche.
Ms. Darche serves as a Director of Groupe Germain Inc. and 48North Cannabis Corporation.
Btw, CEO owns 46% at an average porchase price of $21.1/sh. he hasn't sold even a single share . I believe it could be a life changer investment.
DTEA - of all the fascinating comments pro and con about DTEA over at the S.Alpha comment threads on different articles, this was one of the most illuminating, imo, from a shareholder, back when the stock was still trading around $3 before the Oct. stockmarket correction:
-------------
https://seekingalpha.com/article/4209712-davids-tea-latest-victim-current-cannabis-frenzy
COMMENTS
[...]
Scarborough Eddie
The company isn't trading for much more than cash + working capital. And even if the business continued to deteriorate, the brand is worth quite a bit more to an acquirer than it is currently trading for. Unilver for instance paid 4x revenues for Tazo Tea, which would put DavidsTea at $25. So even assuming the worst case scenario, cash plus working capital plus the value to acquirer equals margin of safety *at these levels.* The other issue is whether DT would do a deal. Management is obviously desperate to keep the price down, that's why it continues to furiously issue press releases knocking down the price. But the company is obligated to listen to offers. An acquirer could pay less than revenues and still pay $9/share. The acquirer could sell off the US operations to Unilever or JAB or a franchiser, something that Segal has speculated about in the past. So a deal is doable. It's also clear Segal doesn't want a deal. But it's not entirely up to him. There is a board and he is not in control of the board. Board members could decide to do a deal. Segal may also want to take the company private. The only reason the company is not private right now is that Segal doesnt have the cash. But with a deal he would have the cash to take the company private. Also consider the low valuation plus tiny float. It would not take much to get this stock to 1x revenues. Remember that this company earned EBITDA of $12mm last year and is highly coveted by tea companies like Unilever.
04 Oct 2018,
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |